We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
EMD.AU

Price
0.03
Stock movement down
-0.00 (-6.90%)
Company name
Emyria Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Health Information Services
Market cap
12.44M
Ent value
13.87M
Price/Sales
3.56
Price/Book
5.13
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
16.92%
1 year return
-56.45%
3 year return
-55.43%
5 year return
-17.35%
10 year return
-
Last updated: 2025-04-05

DIVIDENDS

EMD.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales3.56
Price to Book5.13
EV to Sales3.97

FINANCIALS

Per share

Loading...
Per share data
Current share count460.59M
EPS (TTM)-0.03
FCF per share (TTM)-0.02

Income statement

Loading...
Income statement data
Revenue (TTM)3.49M
Gross profit (TTM)-3.17M
Operating income (TTM)-8.78M
Net income (TTM)-13.19M
EPS (TTM)-0.03
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-90.72%
Operating margin (TTM)-251.23%
Profit margin (TTM)-377.71%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash1.57M
Net receivables30.66K
Total current assets1.93M
Goodwill1.56M
Intangible assets522.04K
Property, plant and equipment0.00
Total assets5.43M
Accounts payable504.03K
Short/Current long term debt1.72M
Total current liabilities2.24M
Total liabilities3.00M
Shareholder's equity2.43M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-5.18M
Capital expenditures (TTM)2.08M
Free cash flow (TTM)-7.26M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-544.00%
Return on Assets-243.18%
Return on Invested Capital-381.69%
Cash Return on Invested Capital-210.06%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.03
Daily high0.03
Daily low0.02
Daily Volume601K
All-time high0.49
1y analyst estimate-
Beta0.81
EPS (TTM)-0.03
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
EMD.AUS&P500
Current price drop from All-time high-94.55%-17.56%
Highest price drop-94.55%-56.47%
Date of highest drop4 Apr 20259 Mar 2009
Avg drop from high-57.44%-11.07%
Avg time to new high62 days12 days
Max time to new high848 days1805 days
COMPANY DETAILS
EMD.AU (Emyria Ltd) company logo
Marketcap
12.44M
Marketcap category
Small-cap
Description
Emyria Limited engages in delivering and developing of new treatments for unmet needs in mental health and select neurological conditions in Australia. It develops MDMA-inspired medicines, including EMD-MX1, for faster-acting MDMA with improved side-effect profile for drug-assisted therapies; EMD-MX2, an adjunct for Parkinson's disease to improve side effects of a common treatment; and EMD-MX3 for other neurological indications. The company is also developing EMD-RX7/9, a CBD capsule prescription medicines for complex pain and anxiety which is under preclinical trial program; and provides psychological trauma care facility under the Pax Centre name. It has a collaboration partnership with the University of Western Australia to support the advancement of Emyria's MDMA analogue drug development program, targeting mental health and neurodegenerative diseases, including Parkinson's. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was incorporated in 2018 and is headquartered in Leederville, Australia.
Employees
0
Investor relations
-
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found